Dr. Mehmet Bilen, MD

• Medical Oncology

*Healthgrades does not verify qualifications for medical specialties. Please verify your provider's specialty and qualifications directly with your provider and applicable medical board.

• Maulana Azad Institute Of Medical Sciences

  Medical School, 2008

• Metastatic Clear-Cell Renal Cell Carcinoma in the Era of Immune Checkpoint Inhibitors: Therapies and Ongoing Trials, 2022-06-10

• High throughput, label-free isolation of circulating tumor cell clusters in meshed microwells, 2022-06-13

• Comparison of outcomes in patients with muscle-invasive bladder cancer treated with radical cystectomy versus bladder preservation, 2018-06-02

• Impact of COVID-19 in patients on active melanoma therapy and with history of melanoma, 2023-03-23

• Therapeutic Vaccines for Genitourinary Malignancies, 2018-08-12

• Biomarker-Directed Therapy in Black and White Men With Metastatic Castration-Resistant Prostate Cancer Biomarker-Directed Therapy in Black and White Men With Metastatic Castration-Resistant Prostate Cancer, 2023-09-18

• Phase 1 safety and pharmacodynamic study of lenalidomide combined with everolimus in patients with advanced solid malignancies with efficacy signal in adenoid cystic carcinoma, 2020-07-24

• Cabozantinib in advanced non-clear-cell renal cell carcinoma: a multicentre, retrospective, cohort study, 2019-02-28

• Advances in Knowledge and Management of Immune-Related Adverse Events in Cancer Immunotherapy, 2022-03-22

• Clinical Characteristics, Racial Inequities, and Outcomes in Patients with Breast Cancer and COVID-19: A COVID-19 and Cancer Consortium (CCC19) Cohort Study, 2023-03-10

• Understanding Immunotherapy Terminology: An Analysis of Provider-Patient Conversations, 2021-09-02

• Assessment of Regional Variability in COVID-19 Outcomes Among Patients With Cancer in the United States Regional Variability in COVID-19 Outcomes Among Patients With Cancer in the United States, 2022-01-04

• Demographics, Outcomes, and Risk Factors for Patients with Sarcoma and COVID-19: A CCC19-Registry Based Retrospective Cohort Study, 2022-09-05

• Impact of performance status on treatment outcomes: A real-world study of advanced urothelial cancer treated with checkpoint inhibitors, 2019-12-12

• Durable complete response for oligometastatic renal cell carcinoma with immune checkpoint inhibition and cytoreductive nephrectomy in a Jehovah's witness: A case report, 2022-12-02

• Neoadjuvant Cabozantinib in an Unresectable Locally Advanced Renal Cell Carcinoma Patient Leads to Downsizing of Tumor Enabling Surgical Resection: A Case Report, 2021-02-01

• Prognostic Evaluation of Metastatic Castration Resistant Prostate Cancer and Neuroendocrine Prostate Cancer with [68Ga]Ga DOTATATE PET-CT, 2022-12-08

• Intratumoral heterogeneity and chemoresistance in nonseminomatous germ cell tumor of the testis, 2016-11-16

• Novel risk scoring system for metastatic renal cell carcinoma patients treated with cabozantinib, 2021-05-09

• Genomic landscape of advanced prostate cancer patients withBRCA1versusBRCA2mutations as detected by comprehensive genomic profiling of cell-free DNA, 2022-09-15

• Negative enrichment of circulating tumor cells from unmanipulated whole blood with a 3D printed device, 2021-10-18

• Sites of metastasis and association with clinical outcome in advanced stage cancer patients treated with immunotherapy, 2019-08-29

• THE ADDITION OF CHEMOTHERAPY IN THE DEFINITIVE MANAGEMENT OF HIGH RISK PROSTATE CANCER, 2018-10-09

• Body Composition Variables as Radiographic Biomarkers of Clinical Outcomes in Metastatic Renal Cell Carcinoma Patients Receiving Immune Checkpoint Inhibitors, 2021-07-09